|
|
Article: S-P to begin distribution of drug using CIMA's OraSolv.(Schering-Plough Corp., CIMA LABS Inc.)(Brief Article)
- Article from:
- Pharma Marketletter
- Article date:
- September 5, 2005
CopyrightCOPYRIGHT 2005 Marketletter Publications Ltd. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
CIMA LABS, a division of US biotechnology firm Cephalon, says that Schering-Plough plans to market an orally-disintegrating version of Clarinex (desloratadine), its prescription antihistamine product, using OraSolv, its proprietary orally-disintegrating drug delivery technology developed by CIMA LABS.
The novel formulation was approved by the US Food and Drug Administration in July and Schering-Plough plans to begin distribution to this market in September.
...